A Randomized Controlled Study of Uterine Incision Diverticulum Repair vs. no Repair During Second/Third Cesarean Section
Launched by SHANGHAI FIRST MATERNAL AND INFANT HEALTH HOSPITAL AFFILIATED TO TONGJI UNIVERSITY MEDICAL SCHOOL · Sep 23, 2024
Trial Information
Current as of June 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a surgical procedure called uterine incision diverticulum repair during a second or third cesarean section. The main goal is to find out if this procedure can help reduce heavy menstrual bleeding (called menorrhagia) and to ensure that it is safe for women undergoing repeat cesarean deliveries. Participants will be randomly assigned to either the group that receives the repair during their cesarean section or to a control group that has a standard cesarean section without the repair.
To be eligible for this study, women must be at least 18 years old, pregnant with one baby, and have had a previous cesarean section. They also need to have a specific condition called uterine incision diverticulum, which is identified by imaging tests. After the surgery, participants will return to the hospital for a check-up 42 days later and will be followed up by phone 6 to 12 months after their operation. It’s important to know that the trial is not yet recruiting participants, so there’s no need to sign up immediately.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women aged ≥18 years, gestational age ≥37 weeks, singleton pregnancy, previous lower segment cesarean section, second or third cesarean section, and diagnosed with uterine incision diverticulum by imaging before or during early pregnancy.
- Exclusion Criteria:
- • Preoperative indications of placenta accreta or previa, interdelivery interval less than 18 months from the last cesarean section, history of other uterine surgeries, and severe obstetric or medical complications requiring emergency care.
About Shanghai First Maternal And Infant Health Hospital Affiliated To Tongji University Medical School
Shanghai First Maternal and Infant Health Hospital, affiliated with Tongji University Medical School, is a leading institution dedicated to advancing maternal and child health through innovative clinical research and high-quality patient care. With a commitment to improving health outcomes for mothers and infants, the hospital leverages its academic affiliation to integrate cutting-edge medical practices with comprehensive clinical trials. The institution fosters a collaborative environment that promotes interdisciplinary research, ensuring that its studies are grounded in scientific rigor and aimed at addressing the most pressing health challenges faced by families today.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported